ARTD1 regulates cyclin E expression and consequently cell-cycle re-entry and G₁/S progression in T24 bladder carcinoma cells

References

• Murray AH, Hunt T. The cell cycle: an introduction. New York: Oxford University Press, 1993.
   Google Scholar
• Takahashi Y, Rayman JB, Dynlacht BD. Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev 2000; 14:804-16; PMID:10766737
   PubMed Web of Science ®Google Scholar
• Ren S, Rollins BJ. Cyclin C/cdk3 promotes Rb-dependent G0 exit. Cell 2004; 117:239-51; PMID:15084261; http://dx.doi.org/10.1016/S0092-8674(04)00300-9
   PubMed Web of Science ®Google Scholar
• Rissland OS, Hong SJ, Bartel DP. MicroRNA destabilization enables dynamic regulation of the miR-16 family in response to cell-cycle changes. Mol Cell 2011; 43:993-1004; PMID:21925387; http://dx.doi.org/10.1016/j.molcel.2011.08.021
   PubMed Web of Science ®Google Scholar
• Sage J. Cyclin C makes an entry into the cell cycle. Dev Cell 2004; 6:607-8; PMID:15130482; http://dx.doi.org/10.1016/S1534-5807(04)00137-6
   PubMed Web of Science ®Google Scholar
• Chatterjee SJ, George B, Goebell PJ, Alavi-Tafreshi M, Shi SR, Fung YK, Jones PA, Cordon-Cardo C, Datar RH, Cote RJ. Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer. J Pathol 2004; 203:762-70; PMID:15221935; http://dx.doi.org/10.1002/path.1567
   PubMed Web of Science ®Google Scholar
• Cobrinik D. Pocket proteins and cell cycle control. Oncogene 2005; 24:2796-809; PMID:15838516; http://dx.doi.org/10.1038/sj.onc.1208619
   PubMed Web of Science ®Google Scholar
• Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev 1998; 12:2245-62; PMID:9694791; http://dx.doi.org/10.1101/gad.12.15.2245
   PubMed Web of Science ®Google Scholar
• Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol 2003; 13:65-70; PMID:12559756; http://dx.doi.org/10.1016/S0962-8924(02)00043-0
   PubMed Web of Science ®Google Scholar
• Sheaff RJ, Groudine M, Gordon M, Roberts JM, Clurman BE. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev 1997; 11:1464-78; PMID:9192873; http://dx.doi.org/10.1101/gad.11.11.1464
   PubMed Web of Science ®Google Scholar
• Ame JC, Rolli V, Schreiber V, Niedergang C, Apiou F, Decker P, Muller S, Hoger T, Menissier-de Murcia J, de Murcia G. PARP-2, A novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase. J Biol Chem 1999; 274:17860-8; PMID:10364231; http://dx.doi.org/10.1074/jbc.274.25.17860
   PubMed Web of Science ®Google Scholar
• Kanai M, Uchida M, Hanai S, Uematsu N, Uchida K, Miwa M. Poly(ADP-ribose) polymerase localizes to the centrosomes and chromosomes. Biochem Biophys Res Commun 2000; 278:385-9; PMID:11097846; http://dx.doi.org/10.1006/bbrc.2000.3801
   PubMed Web of Science ®Google Scholar
• Saxena A, Wong LH, Kalitsis P, Earle E, Shaffer LG, Choo KH. Poly(ADP-ribose) polymerase 2 localizes to mammalian active centromeres and interacts with PARP-1, Cenpa, Cenpb and Bub3, but not Cenpc. Hum Mol Genet 2002; 11:2319-29; PMID:12217960; http://dx.doi.org/10.1093/hmg/11.19.2319
   PubMed Web of Science ®Google Scholar
• Saxena A, Saffery R, Wong L, Kalitsis P, Choo K. Centromere proteins Cenpa, Cenpb, and Bub3 interact with poly(ADP-ribose) polymerase-1 protein and are poly(ADP-ribosyl)ated. J Biol Chem 2002; 277:26921-6; PMID:12011073; http://dx.doi.org/10.1074/jbc.M200620200
   PubMed Web of Science ®Google Scholar
• Monaco L, Kolthur-Seetharam U, Loury R, Murcia JM, de Murcia G, Sassone-Corsi P. Inhibition of Aurora-B kinase activity by poly(ADP-ribosyl)ation in response to DNA damage. Proc Natl Acad Sci USA 2005; 102:14244-8; PMID:16179389; http://dx.doi.org/10.1073/pnas.0506252102
   PubMed Web of Science ®Google Scholar
• Caiafa P, Guastafierro T, Zampieri M. Epigenetics: poly(ADP-ribosyl)ation of PARP-1 regulates genomic methylation patterns. FASEB J 2009; 23:672-8; PMID:19001527; http://dx.doi.org/10.1096/fj.08-123265
   PubMed Web of Science ®Google Scholar
• Wesierska-Gadek J, Schloffer D, Gueorguieva M, Uhl M, Skladanowski A. Increased susceptibility of poly(ADP-ribose) polymerase-1 knockout cells to antitumor triazoloacridone C-1305 is associated with permanent G2 cell cycle arrest. Cancer Res 2004; 64:4487-97; PMID:15231658; http://dx.doi.org/10.1158/0008-5472.CAN-03-3410
   PubMed Web of Science ®Google Scholar
• Tanuma S, Kanai Y. Poly(ADP-ribosyl)ation of chromosomal proteins in the HeLa S3 cell cycle. J Biol Chem 1982; 257:6565-70; PMID:7042716
   PubMed Web of Science ®Google Scholar
• Tentori L, Muzi A, Dorio AS, Scarsella M, Leonetti C, Shah GM, Xu W, Camaioni E, Gold B, Pellicciari R, et al. Pharmacological inhibition of poly(ADP-ribose) polymerase (PARP) activity in PARP-1 silenced tumour cells increases chemosensitivity to temozolomide and to a N3-adenine selective methylating agent. Curr Cancer Drug Targets 2010; 10:368-83; PMID:20464779; http://dx.doi.org/10.2174/156800910791208571
   PubMed Web of Science ®Google Scholar
• Kashima L, Idogawa M, Mita H, Shitashige M, Yamada T, Ogi K, Suzuki H, Toyota M, Ariga H, Sasaki Y, et al. CHFR protein regulates mitotic checkpoint by targeting PARP-1 protein for ubiquitination and degradation. J Biol Chem 2012; 287:12975-84; PMID:22337872; http://dx.doi.org/10.1074/jbc.M111.321828
   PubMed Web of Science ®Google Scholar
• Wright RH, Castellano G, Bonet J, Le Dily F, Font-Mateu J, Ballare C, Nacht AS, Soronellas D, Oliva B, Beato M. CDK2-dependent activation of PARP-1 is required for hormonal gene regulation in breast cancer cells. Genes Dev 2012; 26:1972-83; PMID:22948662; http://dx.doi.org/10.1101/gad.193193.112
   PubMed Web of Science ®Google Scholar
• Madison DL, Lundblad JR. C-terminal binding protein and poly(ADP)ribose polymerase 1 contribute to repression of the p21(waf1/cip1) promoter. Oncogene 2010; 29:6027-39; PMID:20711239; http://dx.doi.org/10.1038/onc.2010.338
   PubMed Web of Science ®Google Scholar
• Simbulan-Rosenthal CM, Rosenthal DS, Luo R, Samara R, Espinoza LA, Hassa PO, Hottiger MO, Smulson ME. PARP-1 binds E2F-1 independently of its DNA binding and catalytic domains, and acts as a novel coactivator of E2F-1-mediated transcription during re-entry of quiescent cells into S phase. Oncogene 2003; 22:8460-71; PMID:14627987; http://dx.doi.org/10.1038/sj.onc.1206897
   PubMed Web of Science ®Google Scholar
• Simbulan-Rosenthal CM, Rosenthal DS, Luo R, Smulson ME. Poly(ADP-ribose) polymerase upregulates E2F-1 promoter activity and DNA pol alpha expression during early S phase. Oncogene 1999; 18:5015-23; PMID:10490838; http://dx.doi.org/10.1038/sj.onc.1202900
   PubMed Web of Science ®Google Scholar
• Carbone M, Rossi MN, Cavaldesi M, Notari A, Amati P, Maione R. Poly(ADP-ribosyl)ation is implicated in the G0-G1 transition of resting cells. Oncogene 2008; 27:6083-92; PMID:18663363; http://dx.doi.org/10.1038/onc.2008.221
   PubMed Web of Science ®Google Scholar
• Chang P, Jacobson MK, Mitchison TJ. Poly(ADP-ribose) is required for spindle assembly and structure. Nature 2004; 432:645-9; PMID:15577915; http://dx.doi.org/10.1038/nature03061
   PubMed Web of Science ®Google Scholar
• Chang P, Coughlin M, Mitchison TJ. Tankyrase-1 polymerization of poly(ADP-ribose) is required for spindle structure and function. Nat Cell Biol 2005; 7:1133-9; PMID:16244666; http://dx.doi.org/10.1038/ncb1322
   PubMed Web of Science ®Google Scholar
• Guetg C, Scheifele F, Rosenthal F, Hottiger MO, Santoro R. Inheritance of silent rDNA chromatin is mediated by PARP1 via noncoding RNA. Mol Cell 2012; 45:790-800; PMID:22405650; http://dx.doi.org/10.1016/j.molcel.2012.01.024
   PubMed Web of Science ®Google Scholar
• Horton J, Stefanick D, Naron J, Kedar P, Wilson S. Poly(ADP-ribose) polymerase activity prevents signaling pathways for cell cycle arrest after DNA methylating agent exposure. J Biol Chem 2005; 280:15773-85; PMID:15701627; http://dx.doi.org/10.1074/jbc.M413841200
   PubMed Web of Science ®Google Scholar
• Bäckert S. Involvement of PARP1 in NF-κB-dependent gene expression during the cell cycle. University of Zurich, Vetsuisse Faculty, 2009. http://dx.doi.org/10.5167/uzh-32472 (D.V.M. thesis)
   Google Scholar
• Peng CC, Chen KC, Peng RY, Su CH, Hsieh-Li HM. Human urinary bladder cancer T24 cells are susceptible to the Antrodia camphorata extracts. Cancer Lett 2006; 243:109-19; PMID:16455193; http://dx.doi.org/10.1016/j.canlet.2005.11.021
   PubMed Web of Science ®Google Scholar
• Cooper MJ, Haluschak JJ, Johnson D, Schwartz S, Morrison LJ, Lippa M, Hatzivassiliou G, Tan J. p53 mutations in bladder carcinoma cell lines. Oncol Res 1994; 6:569-79; PMID:7787250
   PubMed Web of Science ®Google Scholar
• Jin Y, Xu X, Yang M, Wei F, Ayi T, Bowcock A, Baer R. Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains. Proc Natl Acad Sci USA 1997; 94:12075-80; PMID:9342365; http://dx.doi.org/10.1073/pnas.94.22.12075
   PubMed Web of Science ®Google Scholar
• Chen Y, Farmer AA, Chen CF, Jones DC, Chen PL, Lee WH. BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res 1996; 56:3168-72; PMID:8764100
   PubMed Web of Science ®Google Scholar
• Ohtani K, DeGregori J, Nevins JR. Regulation of the cyclin E gene by transcription factor E2F1. Proc Natl Acad Sci U S A 1995; 92:12146-50; PMID:8618861; http://dx.doi.org/10.1073/pnas.92.26.12146
   PubMed Web of Science ®Google Scholar
• Ku M, Jaffe JD, Koche RP, Rheinbay E, Endoh M, Koseki H, Carr SA, Bernstein BE. H2A.Z landscapes and dual modifications in pluripotent and multipotent stem cells underlie complex genome regulatory functions. Genome Biol 2012; 13:R85; PMID:23034477; http://dx.doi.org/10.1186/gb-2012-13-10-r85
   PubMed Web of Science ®Google Scholar
• Garcia-Bassets I, Kwon Y-S, Telese F, Prefontaine G, Hutt K, Cheng C, Ju B-G, Ohgi K, Wang J, Escoubet-Lozach L, et al. Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 2007; 128:505-18; PMID:17289570; http://dx.doi.org/10.1016/j.cell.2006.12.038
   PubMed Web of Science ®Google Scholar
• Krishnakumar R, Kraus W. PARP-1 regulates chromatin structure and transcription through a KDM5B-dependent pathway. Mol Cell 2010; 39:736-49; PMID:20832725; http://dx.doi.org/10.1016/j.molcel.2010.08.014
   PubMed Web of Science ®Google Scholar
• Minotti R, Andersson A, Hottiger MO. ARTD1 Suppresses Interleukin 6 Expression by Repressing MLL1-Dependent Histone H3 Trimethylation. Mol Cell Biol 2015; 35:3189-99; PMID:26149390; http://dx.doi.org/10.1128/MCB.00196-15
   PubMed Web of Science ®Google Scholar
• Krishnakumar R, Gamble M, Frizzell K, Berrocal J, Kininis M, Kraus W. Reciprocal binding of PARP-1 and histone H1 at promoters specifies transcriptional outcomes. Science 2008; 319:819-21; PMID:18258916; http://dx.doi.org/10.1126/science.1149250
   PubMed Web of Science ®Google Scholar
• Luo X, Kraus WL. On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1. Genes Dev 2012; 26:417-32; PMID:22391446; http://dx.doi.org/10.1101/gad.183509.111
   PubMed Web of Science ®Google Scholar
• Ofir M, Hacohen D, Ginsberg D. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E. Mol Cancer Res 2011; 9:440-7; PMID:21454377; http://dx.doi.org/10.1158/1541-7786.MCR-10-0344
   PubMed Web of Science ®Google Scholar
• Lents NH, Baldassare JJ. CDK2 and cyclin E knockout mice: lessons from breast cancer. Trends Endocrinol Metab 2004; 15:1-3; PMID:14693416; http://dx.doi.org/10.1016/j.tem.2003.10.011
   PubMed Web of Science ®Google Scholar
• Russo AA, Jeffrey PD, Patten AK, Massague J, Pavletich NP. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 1996; 382:325-31; PMID:8684460; http://dx.doi.org/10.1038/382325a0
   PubMed Web of Science ®Google Scholar
• Philipp-Staheli J, Payne SR, Kemp CJ. p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Exp Cell Res 2001; 264:148-68; PMID:11237531; http://dx.doi.org/10.1006/excr.2000.5143
   PubMed Web of Science ®Google Scholar
• Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999; 13:1501-12; PMID:10385618; http://dx.doi.org/10.1101/gad.13.12.1501
   PubMed Web of Science ®Google Scholar
• Santoro R, Li J, Grummt I. The nucleolar remodeling complex NoRC mediates heterochromatin formation and silencing of ribosomal gene transcription. Nat Genet 2002; 32:393-6; PMID:12368916; http://dx.doi.org/10.1038/ng1010
   PubMed Web of Science ®Google Scholar
• Bartolomei G, Leutert M, Manzo M, Baubec T, Hottiger MO. Analysis of Chromatin ADP-Ribosylation at the Genome-wide Level and at Specific Loci by ADPr-ChAP. Mol Cell 2016; 61:474-85; PMID:26833088; http://dx.doi.org/10.1016/j.molcel.2015.12.025
   PubMed Web of Science ®Google Scholar